Primary course vaccination is recommended for all children aged 5 - <12 years. The recommended schedule is 2 doses, 8 weeks apart. An additional (3rd) primary dose is recommended for severely immunocompromised children, which should be given 8 weeks after the second dose.
After completing a primary course, a 2023 dose can be considered for children aged 5 - <12 years who have medical comorbidities that increase their risk of severe COVID-19 or disability with significant or complex health needs, and whose last COVID-19 vaccine dose was 6 months ago or longer.
Children who become eligible to consider a 2023 dose can continue to receive this dose until updated advice becomes available in early 2024.
Omicron XBB.1.5-based vaccines are preferred for the primary course and for further doses in this age group. Children aged 5 - <12 years can receive Comirnaty Omicron XBB.1.5 5 - <12 years formulation (light blue cap).
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.